Litigation Details for FWK Holdings, LLC v. Allergan, Inc. (E.D.N.Y 2018)
✉ Email this page to a colleague
FWK Holdings, LLC v. Allergan, Inc. (E.D.N.Y 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-02-06 |
| Court | District Court, E.D. New York | Date Terminated | 2023-08-01 |
| Cause | 15:1 Antitrust Litigation | Assigned To | Nina Gershon |
| Jury Demand | Plaintiff | Referred To | Lois Bloom |
| Patents | 8,629,111; 8,633,162; 8,642,556; 8,648,048; 8,685,930; 9,248,191 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in FWK Holdings, LLC v. Allergan, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for FWK Holdings, LLC v. Allergan, Inc. (E.D.N.Y 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2017-11-16 | 1 | early 2014 as U.S. Patent Nos. 8,629,111 (“the ’111 patent”), 8,633,162 (“the ’162 patent”), 8,642,556 (“…second wave patents which Allergan has claimed cover Restasis: U.S. Patent No. 8,629,111 (dated Jan. ….S. Patent No. 4,839,342 to Kaswan (“the ’342 patent” or “the Kaswan patent”). The Kaswan patent claimed… Ding I patent. 66. The second patent, U.S. Patent No. 5,981,607 (“the ’607 patent” or “the…protected by the U.S. Patent No. 5, 474, 979 (the “979 Patent” or “Ding I patent,” which issued in 1995 | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
